国内外不同主体对药品不良反应报告的认知、态度与实践研究综述

摘要/Abstract

摘要： 药品不良反应（ADR）自发报告是药物警戒的重要组成部分,然而全球普遍存在漏报现象。通过综述国内外不同ADR报告主体如药品生产企业、药品经营企业、医疗机构、患者（公众）等对ADR报告的认知、态度与实践研究,发掘ADR自发报告的主要制约因素,为改善我国的ADR自发报告工作提供参考。

关键词: 药品不良反应报告, 认识, 态度, 实践

Abstract: Though spontaneous reporting of adverse drug reactions (ADR) plays a critical role in pharmacovigilance, the under-reporting phenomenon is common around the world. This paper mainly reviewed the studies on the knowledge, attitude, and practice toward ADR reporting among different reporting entity such as pharmaceutical production enterprises, drug handling enterprises, medical institutions, and patients (publics) at home and abroad, in order to explore the main constraints in ADR spontaneous reporting and to provide references in improving the ADR spontaneous reporting work in our country.

Key words: adverse drug reaction reporting, knowledge, attitude, practice

中图分类号:

R994.11

徐晓娣. 国内外不同主体对药品不良反应报告的认知、态度与实践研究综述[J]. 中国药物警戒, 2019, 16(4): 239-243.

XU Xiaodi. Review of the Studies on the Knowledge, Attitude and Practice toward Adverse Drug Reactions Reporting among Different Reporting Entity at Home and Abroad[J]. Chinese Journal of Pharmacovigilance, 2019, 16(4): 239-243.

参考文献

[1] Kharkar M, Bowalekar S.Knowledge, attitude and perception/practices (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting[J]. Perspect Clin Res, 2012, 3(3): 90-94.
[2] 余超, 高菁, 周鹃, 等. 江西省药品生产企业人员对药品不良反应监测认知情况的调查分析[J]. 中国药房, 2014, 25(12): 1073-1076.
[3] 田克仁, 高菁, 缪健, 等. 我省药品生产企业药品不良反应监测和工作体系分析[J]. 中国药物警戒, 2014, 11(5): 285-287, 290.
[4] 马丹华, 王玲, 孙骏, 等. 我国药品生产企业不良反应术语认知及使用现状调查研究[J]. 药学与临床研究, 2017, 25(4): 369-372.
[5] 李嘉伟, 刘佐仁, 曾颖珊, 等. 广东省药品生产企业不良反应监测现状调查分析[J]. 中国药事, 2015, 29(5): 552-558.
[6] 张雪梅, 郭佳栋, 冯变玲, 等. 药品生产企业药品不良反应工作的调查研究[J]. 医药导报, 2016, 35(8): 902-905.
[7] 黄绿兰, 李洁, 何爱娇, 等. 郴州市2015年生产经营企业上报的药品不良反应1329例分析[J]. 湘南学院学报(医学版), 2016, 18(4): 39-42.
[8] Laven A, Schmitz K, Franzen W H.Reporting adverse drug reactions: contribution, knowledge and perception of German pharmacy professionals[J]. Int J Clin Pharm, 2018, 40(4):842-851.
[9] O'Callaghan J, Griffin B T, Morris J M, et al. Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland[J]. BioDrugs, 2018, 32(3): 267-280.
[10] Moore T J, Furberg C D, Mattison D R, et al.Completeness of serious adverse drug event reports received by the US Food and Drug Administration in 2014[J]. Pharmacoepidemiol Drug Saf, 2016, 25(6): 713-718.
[11] Plessis L, Gómez A, García N, et al.Lack of essential information in spontaneous reports of adverse drug reactions in Catalonia-a restraint to the potentiality for signal detection[J]. Eur J Clin Pharmacol, 2017, 73(6): 751-758.
[12] Ma P, Marinovic I, Karaca-Mandic P.Drug Manufacturers' Delayed Disclosure of Serious and Unexpected Adverse Events to the US Food and Drug Administration[J]. JAMA Intern Med, 2015, 175(9): 1565-1566.
[13] 白军锋, 冯变玲, 郭佳栋, 等. 陕西省药品经营企业药品不良反应报告调查分析[J]. 西北药学杂志, 2015, 30(6): 754-756.
[14] 张芙群. 基层药品零售企业药品不良反应监测工作探讨[J]. 中国药房, 2016, 27(16): 2298-2300.
[15] Hajj A, Hallit S, Ramia E, et al.Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon[J]. Curr Med Res Opin, 2018, 34(1):149-156.
[16] Elkalmi R M, Hassali M A, Ibrahim M I, et al.Community pharmacists' attitudes, perceptions, and barriers toward adverse drug reaction reporting in Malaysia: a quantitative insight[J]. J Patient Saf, 2014, 10(2): 81-87.
[17] 冯变玲, 杨世民, 赵晓红, 等. 陕西省药品不良反应报告主体工作现状的实证研究[J]. 医药导报, 2015, 34(10): 1401-1405.
[18] 李昂, 张冰, 张晓朦, 等. 1109所基层医疗机构的药品不良反应认知及呈报情况调研[J].中国药物警戒, 2017, 14(5): 289-294.
[19] 范蓓蓓, 苟小军, 杨晓露, 等. 我院不同职业和职称医务人员对药品不良反应认知度调查[J]. 中国药房, 2016, 27(15): 2024-2027.
[20] 蔡俊, 张海霞. 不同专业医务人员对药品不良反应关联性评价结果的比较[J]. 药学服务与研究, 2018, 18(2): 143-145.
[21] Nisa Z U, Zafar A, Sher F.Assessment of knowledge, attitude and practice of adverse drug reaction reporting among healthcare professionals in secondary and tertiary hospitals in the capital of Pakistan[J]. Saudi Pharm J, 2018, 26(4): 453-461.
[22] Peymani P, Tabrizi R, Afifi S, et al.Knowledge, attitude and practice of General Practitioners towards adverse drug reaction reporting in South of Iran, Shiraz (Pharmacoepidemiology report)[J]. Int J Risk Saf Med, 2016, 28(1): 25-31.
[23] Shroukh W A, Shakhatreh F M, Yasein N A, et al.A survey on the knowledge, attitudes and practices of physicians towards pharmacovigilance in Jordanian health centres[J]. Int Health, 2018, 10(5): 363-370.
[24] Alsaleh F M, Alzaid S W, Abahussain E A, et al.Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait[J]. Saudi Pharm J, 2017, 25(6): 830-837.
[25] 郭圣敏, 杨建晓, 丁智晓, 等. 2010、2015年我市普通公众对药物不良反应认知度的对比分析[J]. 实用药物与临床, 2016, 19(8): 1054-1057.
[26] 胡永建, 梁世民, 申梦迪, 等. 河南省居民药品不良反应认知调查[J]. 中国公共卫生, 2018, 34(2): 234-237.
[27] 王成岗, 王东芳, 许莉莉, 等. 我国药品不良反应公众报告的需求调研及思考[J]. 中国药物警戒, 2017, 14(7): 402-406.
[28] Rolfes L, van Hunsel F, van der Linden L, et al. The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis[J]. Drug Saf, 2017, 40(7): 607-614.
[29] van Hunsel F, de Waal S, H rmark L. The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015[J]. Pharmacoepidemiol Drug Saf, 2017, 26(8): 977-983.
[30] Kheloufi F, Default A, Rouby F, et al.Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre[J].Eur J Clin Pharmacol, 2017, 73(8): 1009-1018.
[31] Dobashi A, Kurata K, Okazaki M, et al.Analysis of spontaneous inquiries about suspected adverse drug reactions posted by the general public on the electronic Japanese bulletin board "Yahoo! Japan Chiebukuro"[J]. Patient Prefer Adherence, 2016, 10: 511-521.
[32] Sales I, Aljadhey H, Albogami Y, et al.Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi Arabia[J]. Saudi Pharm J, 2017, 25(6): 868-872.
[33] Patsuree A, Krska J, Jarernsiripornkul N.Experiences relating to adverse drug reactions in the community: a cross-sectional survey among patients and the general public in Thailand[J]. Expert Opin Drug Saf, 2016, 15(3): 287-295.
[34] Hariraj V, Aziz Z.Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report[J]. Ther Innov Regul Sci, 2018, 52(6):757-763.
[35] 刘汉斌, 李学伟, 昝军民. 对医务人员进行药品不良反应监测和报告的培训效果评价[J]. 卫生职业教育, 2017, 35(18): 82-84.
[36] Subramaniyan Ganesan, Selvarajan Sandhiya, Kishtapati Chenchu Reddy, et al.The Impact of the Educational Intervention on Knowledge, Attitude, and Practice of Pharmacovigilance toward Adverse Drug Reactions Reporting among Health-care Professionals in a Tertiary Care Hospital in South India[J]. J Nat Sci Biol Med, 2017, 8(2): 203-209.
[37] Arici M A, Gelal A, Demiral Y, et al.Short and long-term impact of pharmacovigilance training on the pharmacovigilance knowledge of medical students[J]. Indian J Pharmacol, 2015, 47(4): 436-439.
[38] Osakwe A, Oreagba I, Adewunmi A J, et al.Impact of training on Nigerian healthcare professionals' knowledge and practice of pharmacovigilance[J]. Int J Risk Saf Med, 2013, 25(4): 219-227.
[39] Yu Y M, Lee E.Enhanced knowledge of spontaneous reporting with structured educational programs in Korean community pharmacists: a cross-sectional study[J]. BMC Med Educ, 2017, 17(1): 95.
[40] van Eekeren R, Rolfes L, Koster A S, et al. What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects[J]. Drug Saf, 2018, 41(11):1003-1011.